Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Haefeli, WE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 64 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Falconnier, AD; Haefeli, WE; Schoenenberger, RA; Surber, C; Martin-Facklam, M
      Drug dosage in patients with renal failure optimized by immediate concurrent feedback

      JOURNAL OF GENERAL INTERNAL MEDICINE
    2. Loehrer, FMT; Tschopl, M; Angst, CP; Litynski, P; Jager, K; Fowler, B; Haefeli, WE
      Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease

      ATHEROSCLEROSIS
    3. Tayrouz, Y; Ganssmann, B; Ding, R; Klingmann, A; Aderjan, R; Burhenne, J; Haefeli, WE; Mikus, G
      Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    4. Schlienger, RG; Haefeli, WE; Jick, H; Meier, CR
      Risk of cataract in patients treated with statins

      ARCHIVES OF INTERNAL MEDICINE
    5. Drewe, J; Ball, HA; Beglinger, C; Peng, B; Kemmler, A; Schachinger, H; Haefeli, WE
      Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    6. Hotz, MA; Ritz, R; Linder, L; Scollo-Lavizzari, G; Haefeli, WE
      Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    7. Romerio, SC; Linder, L; Flammer, J; Haefeli, WE
      Correlation between apolipoprotein B and endothelin-1-induced vasoconstriction in humans

      PEPTIDES
    8. Arnet, I; Haefeli, WE
      Overconsumption detected by electronic drug monitoring requires subtle interpretation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    9. Muller-Schweinitzer, E; Brett, W; Zerkowski, HR; Haefeli, WE
      The mechanism of cryoinjury: In vitro studies on human internal mammary arteries

      BRITISH JOURNAL OF PHARMACOLOGY
    10. Reber, A; Budmiger, B; Wenk, M; Haefeli, WE; Wolff, T; Bein, T; Skarvan, K
      Inspired oxygen fraction after cardiopulmonary bypass: effects on pulmonary function with regard to endothelin-1 concentrations and venous admixture

      BRITISH JOURNAL OF ANAESTHESIA
    11. Martin-Facklam, M; Drewe, J; Haefeli, WE
      Drug interactions with the cytochrome P 450 system

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    12. Schlienger, RG; Luscher, TF; Schoenenberger, RA; Haefeli, WE
      Academic detailing improves identification and reporting of adverse drug events

      PHARMACY WORLD & SCIENCE
    13. Ratz, AE; Schlienger, RG; Linder, L; Langewitz, W; Haefeli, WE
      Pharmacokinetics and pharmacodynamics of clomethiazole after oral and rectal administration in healthy subjects

      CLINICAL THERAPEUTICS
    14. Arnet, I; Schoenenberger, RA; Spiegel, R; Haefeli, WE
      Conviction as a basis for compliance and strategies for improving compliance

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    15. Schuerch, LV; Nyfeler, J; Holder, G; Surber, C; Haefeli, WE
      Tablets in stool? An everyday problem!

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    16. Fuchs, P; Haefeli, WE; Ledermann, HR; Wenk, M
      Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    17. Tsakiris, DA; Tschopl, M; Jager, K; Haefeli, WE; Wolf, F; Marbet, GA
      Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease

      ATHEROSCLEROSIS
    18. Todesco, L; Angst, C; Litynski, P; Loehrer, F; Fowler, B; Haefeli, WE
      Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    19. Romerio, SC; Linder, L; Haefeli, WE
      Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Haller, L; Sossouhounto, R; Coulibaly, IM; Dosso, M; Kone, M; Adom, H; Meyer, UA; Betschart, B; Wenk, M; Haefeli, WE; Lobognon, LR; Porquet, M; Kabore, G; Sorenson, F; Reber-Liske, R; Sturchler, D
      Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: A controlled clinical trial

      CHEMOTHERAPY
    21. Rothen, JP; Haefeli, WE; Meyer, UA; Todesco, L; Wenk, M
      Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo

      PHARMACOGENETICS
    22. LOEHRER FMT; ANGST CP; BRUNNER FP; HAEFELI WE; FOWLER B
      EVIDENCE FOR DISTURBED S-ADENOSYLMETHIONINE-S-ADENOSYLHOMOCYSTEINE RATIO IN PATIENTS WITH END-STAGE RENAL-FAILURE - A CAUSE FOR DISTURBED METHYLATION REACTIONS

      Nephrology, dialysis, transplantation
    23. MULLERSCHWEINITZER E; STULZ P; STRIFFELER H; HAEFELI WE
      FUNCTIONAL-ACTIVITY AND TRANSMEMBRANE SIGNALING MECHANISMS AFTER CRYOPRESERVATION OF HUMAN INTERNAL MAMMARY ARTERIES

      Journal of vascular surgery
    24. SCHUERCH LV; LINDER LM; GROUZMANN E; HAEFELI WE
      HUMAN NEUROPEPTIDE-Y POTENTIATES ALPHA-1-ADRENERGIC BLOOD-PRESSURE RESPONSES IN-VIVO

      American journal of physiology. Heart and circulatory physiology
    25. MULLERSCHWEINITZER E; SCHILLING M; HAEFELI WE
      FUNCTIONAL-ACTIVITY OF BRONCHI FROM AN ORGAN DONOR WITH FATAL ASTHMA - STUDIES ON CRYOPRESERVED BRONCHI

      The Journal of asthma
    26. KAUFMANN GR; VOZEH S; WENK M; HAEFELI WE
      SAFETY AND EFFICACY OF A 2-COMPARTMENT BAYESIAN FEEDBACK PROGRAM FOR THERAPEUTIC TOBRAMYCIN MONITORING IN THE DAILY CLINICAL USE AND COMPARISON WITH A NON-BAYESIAN ONE-COMPARTMENT MODEL

      Therapeutic drug monitoring
    27. SCHMASSMANNSUHIJAR D; BULLINGHAM R; GASSER R; SCHMUTZ J; HAEFELI WE
      RHABDOMYOLYSIS DUE TO INTERACTION OF SIMVASTATIN WITH MIBEFRADIL

      Lancet
    28. HUG B; KAESER YA; HAEFELI WE; BATTEGAY M
      ANTIRETROVIRAL THERAPY AND ANTICONVULSANT DRUGS

      Schweizerische medizinische Wochenschrift
    29. SCHUERCH LV; NYFELER J; HOLDER G; SURBER C; HAEFELI WE
      HAUNTING MEDICINES

      American journal of health-system pharmacy
    30. MULLERSCHWEINITZER E; MIHATSCH MJ; SCHILLING M; HAEFELI WE
      FUNCTIONAL RECOVERY OF HUMAN MESENTERIC AND CORONARY-ARTERIES AFTER CRYOPRESERVATION AT - 196-DEGREES-C IN A SERUM-FREE MEDIUM

      Journal of vascular surgery
    31. GASS A; FLAMMER J; LINDER L; ROMERIO SC; GASSER P; HAEFELI WE
      INVERSE CORRELATION BETWEEN ENDOTHELIN-1-INDUCED PERIPHERAL MICROVASCULAR VASOCONSTRICTION AND BLOOD-PRESSURE IN GLAUCOMA PATIENTS

      Graefe's archive for clinical and experimental ophthalmology
    32. VISCHER UM; INGERSLEV J; WOLLHEIM CB; MESTRIES JC; TSAKIRIS DA; HAEFELI WE; KRUITHOF EKO
      ACUTE VON-WILLEBRAND-FACTOR SECRETION FROM THE ENDOTHELIUM IN-VIVO - ASSESSMENT THROUGH PLASMA PROPEPTIDE (VWF-AGII) LEVELS

      Thrombosis and haemostasis
    33. JOANNIDES R; RICHARD V; HAEFELI WE; BENOIST A; LINDER L; LUSCHER TF; THUILLEZ C
      ROLE OF NITRIC-OXIDE IN THE REGULATION OF THE MECHANICAL-PROPERTIES OF PERIPHERAL CONDUIT ARTERIES IN HUMANS

      Hypertension
    34. HAEFELI WE; LINDER L; LUSCHER TF
      QUINAPRILAT INDUCES ARTERIAL VASODILATION MEDIATED BY NITRIC-OXIDE INHUMANS

      Hypertension
    35. KNOLL B; HAEFELI WE; LADEWIG D; STOHLER R
      EARLY RECURRENCE OF WITHDRAWAL SYMPTOMS UNDER PHENYTOIN AND CHRONIC ALCOHOL-USE

      Pharmacopsychiatry
    36. TAMM M; SIEBER C; SCHNYDER F; HAEFELI WE
      MOXONIDINE-INDUCED CHOLESTATIC HEPATITIS

      Lancet
    37. SCHILLER PI; MESSMER SL; HAEFELI WE; SCHLIENGER RG; BIRCHER AJ
      ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA - LATE-ONSET, IRREGULAR COURSE, AND POTENTIAL ROLE OF TRIGGERS

      Allergy
    38. LOEHRER FMT; SCHWAB R; ANGST CP; HAEFELI WE; FOWLER B
      INFLUENCE OF ORAL S-ADENOSYLMETHIONINE ON PLASMA 5-METHYLTETRAHYDROFOLATE, S-ADENOSYLHOMOCYSTEINE, HOMOCYSTEINE AND METHIONINE IN HEALTHY HUMANS

      The Journal of pharmacology and experimental therapeutics
    39. LOEHRER FMT; ANGST CP; HAEFELI WE; JORDAN PP; RITZ R; FOWLER B
      LOW WHOLE-BLOOD S-ADENOSYLMETHIONINE AND CORRELATION BETWEEN 5-METHYLTETRAHYDROFOLATE AND HOMOCYSTEINE IN CORONARY-ARTERY DISEASE

      Arteriosclerosis, thrombosis, and vascular biology
    40. SCHLIENGER RG; FLUSCHER TF; HAEFELI WE
      CLINICAL PHARMACISTS EFFECT ON DRUG INFORMATION REQUESTS

      The Annals of pharmacotherapy
    41. LINDER L; LAUTENSCHLAGER BM; HAEFELI WE
      SUBCONSTRICTOR DOSES OF NEUROPEPTIDE-Y POTENTIATE ALPHA(1)-ADRENERGICVENOCONSTRICTION IN-VIVO

      Hypertension
    42. SCHLIENGER RG; SAXER M; HAEFELI WE
      REVERSIBLE AGEUSIA ASSOCIATED WITH LOSARTAN

      Lancet
    43. STROBEL WM; LUSCHER TF; SIMPER D; LINDER L; HAEFELI WE
      SUBSTANCE-P IN HUMAN HAND VEINS IN-VIVO - TOLERANCE, EFFICACY, POTENCY, AND MECHANISM OF VENODILATOR ACTION

      Clinical pharmacology and therapeutics
    44. KAUFMANN GR; WENK M; TAESCHNER W; PETERLI B; GYR K; MEYER UA; HAEFELI WE
      N-ACETYLTRANSFERASE-2 POLYMORPHISM IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical pharmacology and therapeutics
    45. HAEFELI WE; OTT R; BIRCHER AJ; BURNENS AP
      HAIR LOSS FOLLOWING TYPHOID-FEVER - A FORGOTTEN PHENOMENON

      Clinical infectious diseases
    46. TSAKIRIS DA; HAEFELI WE; LINDER L; STEINER B; MARBET GA
      PLATELET SURFACE ACTIVATION MARKERS AFTER DDAVP INFUSION IN HEALTHY-SUBJECTS

      Thrombosis and haemostasis
    47. JOANNIDES R; RICHARD V; HAEFELI WE; LINDER L; LUSCHER TF; THUILLEZ C
      ROLE OF BASAL AND STIMULATED RELEASE OF NITRIC-OXIDE IN THE REGULATION OF RADIAL ARTERY CALIBER IN HUMANS

      Hypertension
    48. BAUER TM; RITZ R; HABERTHUR C; HA HR; HUNKELER W; SLEIGHT AJ; SCOLLOLAVIZZARI G; HAEFELI WE
      PROLONGED SEDATION DUE TO ACCUMULATION OF CONJUGATED METABOLITES OF MIDAZOLAM

      Lancet
    49. PEDUZZI P; SIMPER D; LINDER L; STROBEL WM; HAEFELI WE
      NEUROPEPTIDE-Y IN HUMAN HAND VEINS - PHARMACOLOGICAL CHARACTERIZATIONAND INTERACTION WITH CYCLIC GUANOSINE MONOPHOSPHATE-DEPENDENT VENODILATORS IN-VIVO

      Clinical pharmacology and therapeutics
    50. JOANNIDES R; RICHARD V; HAEFELI WE; LINDER L; THUILLEZ C
      ROLE OF NITRIC-OXIDE IN THE REGULATION OF THE MECHANICAL-PROPERTIES OF LARGE PERIPHERAL ARTERIES IN HUMANS

      Circulation
    51. JOANNIDES R; HAEFELI WE; LINDER L; RICHARD V; BAKKALI EH; THUILLEZ C; LUSCHER TF
      NITRIC-OXIDE IS RESPONSIBLE FOR FLOW-DEPENDENT DILATATION OF HUMAN PERIPHERAL CONDUIT ARTERIES IN-VIVO

      Circulation
    52. SIMPER D; STROBEL WM; LINDER L; HAEFELI WE
      INDIRECT EVIDENCE FOR STIMULATION OF NITRIC-OXIDE RELEASE BY TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN VEINS IN-VIVO

      Cardiovascular Research
    53. JOANNIDES R; HAEFELI WE; LINDER L; LUSCHER TF; RICHARD V; THUILLEZ C
      EFFECTS OF NITRIC-OXIDE SYNTHASE INHIBITI ON ON THE MECHANICAL-PROPERTIES OF MUSCULAR ARTERIES IN HUMANS

      Archives des maladies du coeur et des vaisseaux
    54. HAEFELI WE; MEYER PG; LUSCHER TF
      CIRCADIAN CARBAMAZEPINE TOXICITY

      Epilepsia
    55. HAEFELI WE; LINDER L; LUSCHER TF
      BLOCKADE OF NITRIC-OXIDE FORMATION INHIBITS DIRECT VASODILATOR EFFECTS OF THE ACE-INHIBITOR QUINAPRILAT

      Circulation
    56. HAEFELI WE; LINDER L; LUSCHER TF
      BLOCKADE OF NITRIC-OXIDE FORMATION INHIBITS DIRECT VASODILATOR EFFECTS OF THE ACE-INHIBITOR QUINAPRILAT

      Circulation
    57. HAEFELI WE; LINDER L; WENK M; LUSCHER TF
      HETEROGENEITY OF VENOUS AND ARTERIAL VASOCONSTRICTOR EFFECTS OF BIG-ENDOTHELIN-1 IN HUMAN FOREARM CIRCULATION IN-VIVO

      Circulation
    58. HAEFELI WE; LINDER L; WENK M; LUSCHER TF
      HETEROGENEITY OF VENOUS AND ARTERIAL VASOCONSTRICTOR EFFECTS OF BIG-ENDOTHELIN-1 IN HUMAN FOREARM CIRCULATION IN-VIVO

      Circulation
    59. JOANNIDES R; HAEFELI WE; LINDER L; RICHARD V; THUILLEZ C; LUSCHER TF
      ROLE OF ENDOTHELIUM-DERIVED NITRIC-OXIDE IN FLOW-DEPENDENT DILATION OF HUMAN PERIPHERAL CONDUIT ARTERIES IN-VIVO

      Archives des maladies du coeur et des vaisseaux
    60. HAEFELI WE; LINDER L; KIOWSKI W; LUSCHER TF
      IN-VIVO PROPERTIES OF ENDOTHELIN-1 AND ENDOTHELIN-3 IN HUMAN HAND VEINS AND ITS REVERSAL BY BRADYKININ AND VERAPAMIL

      Hypertension
    61. SCHOENENBERGER RA; HAEFELI WE; WEISS P; RITZ R
      EVALUATION OF CONVENTIONAL CHEST TUBE THERAPY FOR LATROGENIC PNEUMOTHORAX

      Chest
    62. HAEFELI WE; SRIVASTAVA N; KELSEY KT; WIENCKE JK; HOFFMAN BB; BLASCHKE TF
      GLUTATHIONE S-TRANSFERASE-MU POLYMORPHISM DOES NOT EXPLAIN VARIATION IN NITROGLYCERIN RESPONSIVENESS

      Clinical pharmacology and therapeutics
    63. BEDARIDA GV; BUSHELL E; HAEFELI WE; BLASCHKE TF; HOFFMAN BB
      RESPONSIVENESS TO BRADYKININ IN VEINS OF HYPERCHOLESTEROLEMIC HUMANS

      Circulation
    64. LUSCHER TF; HAEFELI WE
      L-ARGININE IN THE CLINICAL ARENA - TOOL OR REMEDY

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 11:03:14